Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $2.69B
Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $2.69B
Body unavailable. Use the original source.
Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $2.69B
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.